首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1316238

全球心導管和導絲市場 - 2023-2030 年

Global Cardiac Catheters and Guidewires Market - 2023-2030

出版日期: 2023年07月27日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

2022 年，全球心導管和導絲市場規模達到136 億美元，預計到2030 年將實現243 億美元的強勁成長。在預測期內（2023-2030 年），全球心導管和導絲市場的年複合成長率預計將達到7.7%。

心導管和導絲市場包括為特定診斷或介入手術而設計的各類導管。其中包括血管造影導管、球囊導管、電生理導管和血管內超聲（IVUS）導管等。每種導管在診斷、存取或治療心血管疾病方面都有其獨特的作用。

受心血管疾病發病率上升、技術進步以及向微創手術轉變等因素的影響，全球心導管市場正呈現穩步成長態勢。在心血管疾病的精確診斷和有效治療需求不斷成長的推動下，預計未來幾年市場將繼續保持成長態勢。

市場動態

微創手術的增加推動導管和導絲市場的成長

據Biomed Central 報導，2022 年9 月，一篇名為《微創心臟外科》的文章對影響和力量進行了文獻計量分析，以確定促進高級培訓的關鍵因素。從20 世紀90 年代中期開始，微創技術不斷發展，包括微型胸骨切開術和微型胸廓切開術。

隨著研究和開發的不斷深入，MICS 將在心胸外科培訓中得到高度普及，而確定關鍵的研究領域將有助於指導未來的培訓和研究。

有利的報銷政策推動了心臟導管和導絲市場的成長

報銷政策規定了特定心導管手術向醫療服務提供者提供的報銷額度。這些政策通常會考慮手術的複雜程度、使用的導管類型以及手術過程中使用的相關醫療資源等因素。報銷政策在心導管市場中起著至關重要的作用，因為它們決定了醫療服務提供商在實施心導管手術時的覆蓋範圍和經濟補償水準。

例如，根據衝擊波醫療公司（Shockwave Medical）的數據，2022 年7 月1 日，自2021 年初推出冠狀動脈IVL 以來，衝擊波公司在報銷方面取得了重大進展。他們在門診、ASC 和住院方面都獲得了報銷。

心導管手術的高併發症風險將阻礙市場成長

心導管檢查需要將導管插入血管，這有可能造成血管損傷。這可能包括血管穿孔、剝離（血管壁撕裂）或破裂。血管損傷可能導致出血、血腫形成，甚至需要手術修復。導管內部或周圍可能會形成血栓，從而導致潛在的併發症。血栓會阻礙血流，導致患處缺血或梗塞。為防止血栓形成，可在手術前、手術中或手術後服用抗凝藥物或抗血小板藥物。

據CardioVascular Group 2023 年4 月14 日報導，心導管手術最常見的風險是出血。在手術過程中，需要切開一個小口來插入導管，這可能會導致出血。有時，插入部位周圍會形成血腫或血液聚集。這可能會造成疼痛，並可能需要進一步治療。

心導管手術的另一個風險是感染。由於手術需要進入血液，因此有感染的風險。心導管檢查過程中或之後可能會出現稱為心律失常的心律異常。這可能是手術過程中血流變化或導管與心肌摩擦造成的。大多數心律失常都很輕微，會自行消失，但偶爾也會有危險，需要就醫。

COVID-19 影響分析

COVID-19 大流行對全球心導管和導絲市場產生了重大影響。由於封鎖、旅行限制以及生產和分銷中斷，包括心臟導管和導絲在內的醫療器械全球供應鏈已經中斷。這給某些醫療器械的供應和產品供應波動帶來了挑戰。

在大流行期間，患者可能會推遲定期體檢和篩查，導致通常需要進行心導管手術的心血管疾病的檢測和診斷率下降。患者就診和篩查的減少影響了心導管和導絲的使用。

俄烏衝突分析

衝突造成了俄羅斯和烏克蘭之間的地緣政治緊張局勢、邊界爭端和貿易中斷。這些干擾可能會對包括心臟導管設備在內的醫療設備供應鏈造成潛在影響。如果這些器械的進出口受到限製或延誤，可能會導致供應短缺或延誤，從而影響市場。

持續的衝突導致俄羅斯和烏克蘭的經濟不穩定。經濟衰退和貨幣波動會對醫療保健行業，包括醫療器械市場產生連鎖反應。醫療保健系統購買力下降和預算緊張可能會影響心臟導管和導絲的需求和採購。

在衝突時期，醫療保健的重點往往轉向急診和創傷護理，包括治療與戰爭有關的創傷。這種重點轉移可能會導致對非急診醫療程序的重視程度降低，包括那些需要心臟導管設備的程序。隨著資源轉向更緊急的醫療保健需求，對此類設備的總體需求可能會受到影響。因此，考慮到上述因素，全球心臟導管和導絲市場受到俄羅斯和烏克蘭衝突的影響不大。

Market Overview

The global cardiac catheters and guidewires market reached US$ 13.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 24.3 billion by 2030. The global cardiac catheters and guidewires market is expected to exhibit a CAGR of 7.7% during the forecast period (2023-2030).

The cardiac catheter and guidewire market encompass various types of catheters designed for specific diagnostic or interventional procedures. These include angiography catheters, balloon catheters, electrophysiology catheters, and intravascular ultrasound (IVUS) catheters, among others. Each type of catheter serves a unique purpose in diagnosing, accessing, or treating cardiovascular conditions.

The global cardiac catheter market is witnessing steady growth due to factors such as the increasing prevalence of cardiovascular diseases, technological advancements, and the shift toward minimally invasive procedures. The market is expected to continue its growth trajectory in the coming years, driven by the rising demand for accurate diagnosis and effective treatment of cardiovascular conditions.

Market Dynamics

Increasing Minimally Invasive Procedures Drives the Growth of Catheter and Guidewire Market

According to Biomed Central, in September 2022, an article named Minimally-invasive cardiac surgery conducted a bibliometric analysis of impact and force to identify key and facilitating advanced training which states that minimally-invasive techniques have started to become more prominent as cases become more complex. As of the mid-1990s there are been development of techniques to involve mini-sternotomy and mini-thoracotomy approaches.

With continued research and development, MICS is set to become highly prevalent in Cardiothoracic Surgery training and identifying key areas of research would help to guide training and research in the future.

Favorable Reimbursement Policies are Boosting the Cardiac Catheters and Guidewires Market Growth

Reimbursement policies define the amount of reimbursement provided to healthcare providers for specific cardiac catheterization procedures. These policies often consider factors such as the complexity of the procedure, the type of catheter used, and the associated healthcare resources utilized during the procedure. Reimbursement policies play a crucial role in the cardiac catheter market as they determine the level of coverage and financial reimbursement provided to healthcare providers for performing cardiac catheterization procedures.

For instance, according to Shockwave Medical for instance, on July 1 2022, since the launch of Coronary IVL in early 2021, Shockwave has made deep and significant progress on reimbursement. They have reimbursement in the outpatient, ASC, and inpatient setting.

High Risk of Complications for Cardiac Catheterization Will Hamper the Growth of the Market

Cardiac catheterization involves the insertion of a catheter into blood vessels, which can potentially cause vessel damage. This can include vessel perforation, dissection (tearing of the vessel wall), or rupture. Vessel damage can result in bleeding, hematoma formation, or even require surgical repair. Blood clot formation can occur within or around the catheter, leading to potential complications. Thrombosis can obstruct blood flow, resulting in ischemia or infarction in the affected area. To prevent thrombosis, anticoagulant medications or antiplatelet agents may be administered before, during, or after the procedure.

According to CardioVascular Group, April 14 2023, the most common risks associated with cardiac catheterization is bleeding. During the procedure, a small incision is made to insert the catheter, and this can lead to bleeding. Sometimes, a hematoma, or a collection of blood, can form around the insertion site. This can be painful and may require further treatment.

Another risk of cardiac catheterization is of infection. Since the procedure involves accessing the bloodstream, there is a risk of infection. Heart rhythm abnormalities called arrhythmias can happen during or after cardiac catheterization. These may result from changes in blood flow during the procedure or from the catheter rubbing against the heart muscle. The majority of arrhythmias are small and go away on their own, but they can occasionally be dangerous and need medical attention.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the global cardiac catheters and guidewire market. The global supply chains for medical devices, including cardiac catheters and guidewires have been disrupted due to lockdowns, travel restrictions, and disruptions in manufacturing and distribution. This has led to challenges in the availability of certain medical devices and fluctuations in product supply.

During the pandemic, patients may have postponed regular check-ups and screenings, resulting in decreased detection and diagnosis of cardiovascular conditions that would typically require cardiac catheterization procedures. This decline in patient visits and screenings has impacted the utilization of cardiac catheters and guidewires.

Russia-Ukraine Conflict Analysis

The conflict has created geopolitical tensions, border disputes, and trade disruptions between Russia and Ukraine. These disruptions can potentially affect the supply chain of medical devices, including cardiac catheter devices. If there are restrictions or delays in the import/export of these devices, it could lead to shortages or delays in their availability, impacting the market.

The ongoing conflict has resulted in economic instability in both Russia and Ukraine. Economic downturns and currency fluctuations can have a ripple effect on the healthcare sector, including medical device markets. Reduced purchasing power and budgetary constraints within healthcare systems may impact the demand and procurement of cardiac catheters and guidewires.

During times of conflict, healthcare priorities often shift towards emergency and trauma care, including the treatment of war-related injuries. This shift in focus may result in a reduced emphasis on non-emergency medical procedures, including those requiring cardiac catheter devices. The overall demand for such devices could be impacted as resources are redirected towards more urgent healthcare needs. Therefore, considering the above factors, the global cardiac catheters and guidewires market has been moderately affected by the conflict between Russia and Ukraine.

Segment Analysis

The cardiac catheters and guidewires market is segmented based on product type, application, end-user, and geography.

Owing to the Increasing Prevalence of Cardiovascular Disease, Rising Clinical Trials, the Hospital Segment Accounted for Approximately 45.5% of the Cardiac Catheters and Guidewires Market Share

Hospitals are the primary users of cardiac catheters and guidewires as these devices are essential for performing various cardiovascular procedures. Hospitals generate demand for these devices based on their patient population and the prevalence of cardiovascular diseases in their region. Hospitals are responsible for the procurement and purchasing of cardiac catheters and guidewires. They establish contracts with medical device manufacturers and suppliers to ensure a steady supply of these devices for their cardiovascular departments.

For instance, on April 25 2022, New York-Presbyterian Hudson Valley Hospital launched Interventional Cardiology program and opens state-of-the-art cardiac catheterization lab. It is designed to support cardiac health and bring world-class interventional cardiology care to the Hudson Valley and upper Westchester region. The interventional cardiology program provides a variety of emergent procedures, including cardiac angioplasty to improve blood flow in narrow or blocked arteries for patients experiencing a heart attack or chest pain. Advanced cardiac services include diagnostic cardiac catheterization (a procedure in which a catheter is guided through a blood vessel in the heart to diagnose certain heart conditions) and minimally invasive procedures to open clogged arteries.

Geographical Analysis

North America Accounted for Approximately 39.4% of the Market Share in 2022, Owing to the Increasing Research and Development Activities and Well-Established Healthcare Infrastructure

North America plays a significant role in the cardiac catheter and guidewire market and is a major contributor to its growth. North America, particularly the United States, has a well-developed and advanced healthcare infrastructure. The region is known for its state-of-the-art medical facilities, highly skilled healthcare professionals, and advanced technologies.

This infrastructure supports the adoption and utilization of cardiac catheters in various cardiovascular procedures. It also has a high prevalence of cardiovascular diseases, including coronary artery disease, hypertension, and heart failure. These conditions often require diagnostic and interventional procedures, such as cardiac catheterization, to assess and treat the cardiovascular system. The increasing incidence of these diseases drives the demand for cardiac catheters in the region.

North America is home to several leading medical device manufacturers and market players in the cardiac catheter segment. These companies invest in research and development activities to introduce innovative catheter technologies, enhance procedural outcomes, and improve patient safety. The presence of these established market players further stimulates market growth.

For instance, on Feb 2, 2022. as part of its expanding line of electrophysiological products for the international market, Abbott announced two approvals. The business's TactiFlex Ablation Catheter, Sensor Enabled, the only ablation catheter in the world with a flexible tip and contact force sensing, has been granted CE Mark 1 for the purpose of treating patients with unnatural heart rhythms such atrial fibrillation (AFib). The U.S. Food and Drug Administration (FDA) recently granted an additional indication for using Abbott's FlexAbility Ablation Catheter, Sensor Enabled to treat patients with complicated cardiac conditions.

Competitive Landscape

The major global players in the market include: Abbott Healthcare Pvt. Ltd., Boston Scientific Corp, Biotronic, Medtronic, Terumo Medical Corporation Access, Cordis, Teleflex Inc., Nipro, BrosMed Medical co., Merit Medical System among others

Why Purchase the Report?

To visualize the cardiac catheters and guidewires market segmentation based on the product type, by application, by end-user and by region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of cardiac catheters and guidewires market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global cardiac catheters and guidewires market report would provide approximately 69 tables, 70 figures, and 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Geography

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Technology Advancements in Catheter and Guidewires
  - 4.1.1.2. Increasing Number of Clinical Trials on Cardiac Catheters and Guidewires
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Surgical Procedures and Cardiac Catheters
- 4.1.3. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario before COVID-19
- 6.1.2. Scenario during COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. Russia-Ukraine War Analysis

8. By Product type

8.1. Introduction
8.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.3. Market Attractiveness Index, By Product Type
8.4. Cardiac Catheters
8.5. Introduction
8.6. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.7. Cardiac Guidewires

9. By Application

9.1. Introduction
9.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3. Market Attractiveness Index, By Application
9.4. Balloon Septostomy
9.5. Introduction
9.6. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.7. Coronary Angioplasty
9.8. Catheter Ablation
9.9. Left/Right Heart Catheterization

10. By End Users

10.1. Introduction
10.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
10.3. Market Attractiveness Index, By End Users
10.4. Hospitals
10.5. Clinics
10.6. Ambulatory Surgery Centers

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Geography
  - 11.2.6.1. U.S.
  - 11.2.6.2. Canada
  - 11.2.6.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Geography
  - 11.3.6.1. Germany
  - 11.3.6.2. U.K.
  - 11.3.6.3. France
  - 11.3.6.4. Italy
  - 11.3.6.5. Spain
  - 11.3.6.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Geography
  - 11.4.5.1. Brazil
  - 11.4.5.2. Argentina
  - 11.4.5.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.5.1. China
  - 11.5.5.2. India
  - 11.5.5.3. Japan
  - 11.5.5.4. Australia
  - 11.5.5.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Abbott Healthcare Pvt. Ltd
- 13.1.1. Product Portfolio and Description
- 13.1.2. Financial Overview
13.2. Boston Scientific Corp
13.3. Biotronik
13.4. Medtronic
13.5. Terumo Medical Corporation
13.6. Cordis
13.7. Teleflex Inc
13.8. Nipro
13.9. BrosMed Medical Co
13.10. Merit Medical Sysytem